Literature DB >> 32602980

Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision Medicine.

George V Papatheodoridis1, Thodoris Voulgaris1, Margarita Papatheodoridi1, W Ray Kim2.   

Abstract

Entities:  

Year:  2020        PMID： 32602980     DOI： 10.1002/hep.31440

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

Review 1.  Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control.

Authors:  Pierre Nahon; Erwan Vo Quang; Nathalie Ganne-Carrié
Journal:  J Clin Med       Date:  2021-01-19       Impact factor: 4.241

2.  Long noncoding RNA RP11-241J12.3 targeting pyruvate carboxylase promotes hepatocellular carcinoma aggressiveness by disrupting pyruvate metabolism and the DNA mismatch repair system.

Authors:  Liuliu Cheng; Shichuan Hu; Jinhu Ma; Yongheng Shu; Yanwei Chen; Bin Zhang; Zhongbing Qi; Yunmeng Wang; Yan Zhang; Yuwei Zhang; Ping Cheng
Journal:  Mol Biomed       Date:  2022-02-05

3.  The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B.

Authors:  Hye Won Lee; Hyun Woong Lee; Jae Seung Lee; Yun Ho Roh; Hyein Lee; Seung Up Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Beom Kyung Kim
Journal:  J Hepatocell Carcinoma       Date:  2021-05-25

4.  Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B.

Authors:  George V Papatheodoridis; George N Dalekos; Ramazan Idilman; Vana Sypsa; Florian Van Boemmel; Maria Buti; Jose Luis Calleja; John Goulis; Spilios Manolakopoulos; Alessandro Loglio; Margarita Papatheodoridi; Nikolaos Gatselis; Rhea Veelken; Marta Lopez-Gomez; Bettina E Hansen; Savvoula Savvidou; Anastasia Kourikou; John Vlachogiannakos; Kostas Galanis; Cihan Yurdaydin; Rafael Esteban; Harry L A Janssen; Thomas Berg; Pietro Lampertico
Journal:  JHEP Rep       Date:  2021-04-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.